← Evidence map

ArticleFrontiers in immunology2024

The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.

Rida Rehman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39635532